| Literature DB >> 30583804 |
Raphael Ferreira1, Angelo Limeta2, Jens Nielsen3.
Abstract
The ability to precisely engineer yeast, coupled with its genetic and metabolic similarity to tumor cells, has enabled researchers to use this organism in cancer research. Here we review advances that leveraged yeast as a model organism for studying cancer biology, including the investigation of tumorigenic mechanisms, development of advanced technologies for drug discovery, production of anticancer drugs on an industrial scale, and delivering the next generation of immunotherapies.Entities:
Keywords: CRISPR; SGA; cancer vaccines; humanized antibody; immunotherapy; metabolic engineering
Mesh:
Substances:
Year: 2018 PMID: 30583804 DOI: 10.1016/j.tibtech.2018.11.013
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536